electroCore to Participate in Upcoming Investor Conferences
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in two upcoming investor conferences in August 2025.
The company will attend the Needham 10th Annual Virtual MedTech and Diagnostics Conference on August 11-12, 2025, offering one-on-one meetings. Additionally, management will present at the Canaccord Genuity 45th Annual Growth Conference in Boston on August 12 at 3:30 p.m. ET, also providing one-on-one meeting opportunities during the event.
electroCore (Nasdaq: ECOR), un'azienda nel settore della medicina bioelettronica e del benessere in fase commerciale, ha annunciato la sua partecipazione a due prossime conferenze per investitori ad agosto 2025.
L'azienda sar脿 presente alla Needham 10th Annual Virtual MedTech and Diagnostics Conference l'11 e 12 agosto 2025, offrendo incontri individuali. Inoltre, il management terr脿 una presentazione al Canaccord Genuity 45th Annual Growth Conference a Boston il 12 agosto alle 15:30 ET, fornendo anch'esso opportunit脿 di incontri one-to-one durante l'evento.
electroCore (Nasdaq: ECOR), una empresa comercial de medicina bioelectr贸nica y bienestar, ha anunciado su participaci贸n en dos pr贸ximas conferencias para inversores en agosto de 2025.
La compa帽铆a asistir谩 a la Needham 10th Annual Virtual MedTech and Diagnostics Conference los d铆as 11 y 12 de agosto de 2025, ofreciendo reuniones individuales. Adem谩s, la direcci贸n presentar谩 en la Canaccord Genuity 45th Annual Growth Conference en Boston el 12 de agosto a las 3:30 p.m. ET, tambi茅n brindando oportunidades para reuniones individuales durante el evento.
electroCore (雮橃姢雼�: ECOR)電� 靸侅梾 雼硠鞚� 氚旍澊鞓れ澕霠夗姼搿滊媺 鞚橅暀 氚� 鞗半媹鞀� 須岇偓搿�, 2025雲� 8鞗旍棎 臧滌禍霅橂姅 霊� 瓯挫潣 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟.
須岇偓電� 2025雲� 8鞗� 11鞚茧秬韯� 12鞚缄箤歆� 鞐措Μ電� Needham 10th Annual Virtual MedTech and Diagnostics Conference鞐� 彀胳劃頃橃棳 鞚茧寑鞚� 氙疙寘鞚� 鞝滉车頃╇媹雼�. 霕愴暅 瓴届榿歆勳潃 8鞗� 12鞚� 鞓ろ泟 3鞁� 30攵�(霃欕秬 鞁滉皠)鞐� 氤挫姢韯挫棎靹� 鞐措Μ電� Canaccord Genuity 45th Annual Growth Conference鞐愳劀 氚滍憸毳� 歆勴枆頃橂┌, 頄夓偓 旮瓣皠 霃欖晥 鞚茧寑鞚� 氙疙寘 旮绊殞霃� 鞝滉车頃╇媹雼�.
electroCore (Nasdaq : ECOR), une entreprise de m茅decine bio茅lectronique et de bien-锚tre en phase commerciale, a annonc茅 sa participation 脿 deux prochaines conf茅rences pour investisseurs en ao没t 2025.
L'entreprise assistera 脿 la Needham 10th Annual Virtual MedTech and Diagnostics Conference les 11 et 12 ao没t 2025, proposant des rencontres individuelles. De plus, la direction pr茅sentera lors de la Canaccord Genuity 45th Annual Growth Conference 脿 Boston le 12 ao没t 脿 15h30 ET, offrant 茅galement des opportunit茅s de rencontres en t锚te-脿-t锚te pendant l'茅v茅nement.
electroCore (Nasdaq: ECOR), ein Unternehmen im Bereich bioelektronische Medizin und Wellness in der kommerziellen Phase, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im August 2025 angek眉ndigt.
Das Unternehmen wird an der Needham 10th Annual Virtual MedTech and Diagnostics Conference am 11. und 12. August 2025 teilnehmen und Einzelgespr盲che anbieten. Au脽erdem wird das Management am 12. August um 15:30 Uhr ET auf der Canaccord Genuity 45th Annual Growth Conference in Boston pr盲sentieren und auch dort Einzelgespr盲che w盲hrend der Veranstaltung erm枚glichen.
- None.
- None.
ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences.
- Needham 10th Annual Virtual MedTech and Diagnostics Conference, taking place virtually on Monday, August 11 and Tuesday, August 12, 2025. Management will host will host one-on-one meetings throughout both days.
- Canaccord Genuity 45th Annual Growth Conference, taking place in Massachusetts on Tuesday, August 12 and Wednesday, August 13, 2025 at the InterContinental in Boston. Management will be presenting on Tuesday, August 12 at 3:30 p.m. ET and will host one-on-one meetings throughout both days.
Investors who wish to request a meeting should contact their sales representative at the sponsoring firms or reach out the electroCore Investor Relations at .
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company鈥檚 two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator. Additionally, the company commercializes its Truvaga products,聽handheld, and personal use nVNS products utilizing bioelectronic technologies, to promote general wellness and human performance.
For more information, visit .
Contact
ECOR Investor Relations
(973) 302-9253
FAQ
When is electroCore (ECOR) presenting at the Canaccord Genuity Conference?
How can investors schedule meetings with electroCore management at these conferences?
Which investor conferences will electroCore (ECOR) attend in August 2025?
Where is the Canaccord Genuity Growth Conference being held?
